<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Chem.</journal-id>
<journal-title>Frontiers in Chemistry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Chem.</abbrev-journal-title>
<issn pub-type="epub">2296-2646</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">756745</article-id>
<article-id pub-id-type="doi">10.3389/fchem.2021.756745</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Chemistry</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Vitamin E Acetate Determination in Vaping Liquids and Non-targeted Analysis of Vaping Emissions of Diluents of Concern, Vitamin E Acetate and Medium-Chain Triglycerides Oil</article-title>
<alt-title alt-title-type="left-running-head">Kosarac et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Diluents of concern in vaping products</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kosarac</surname>
<given-names>Ivana</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1319964/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kubwabo</surname>
<given-names>Cariton</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Katuri</surname>
<given-names>Guru Prasad</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Petraccone</surname>
<given-names>Dora</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mischki</surname>
<given-names>Trevor K.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1200852/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>Office of Research and Surveillance, Tobacco Control Directorate, Controlled Substances and Cannabis Branch, Health Canada, <addr-line>Ottawa</addr-line>, <addr-line>ON</addr-line>, <country>Canada</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>Exposure and Biomonitoring Division, Environmental and Radiation Sciences Directorate, Healthy Environments and Consumer Safety Branch, Health Canada, <addr-line>Ottawa</addr-line>, <addr-line>ON</addr-line>, <country>Canada</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/541442/overview">Alberto Salomone</ext-link>, University of Turin, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1247595/overview">Gordon Vrdoljak</ext-link>, California Department of Public Health, United&#x20;States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/554350/overview">Maria Morel Espinosa</ext-link>, Centers for Disease Control and Prevention (CDC), United&#x20;States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Ivana Kosarac, <email>ivana.kosarac@canada.ca</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Analytical Chemistry, a section of the journal Frontiers in Chemistry</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>9</volume>
<elocation-id>756745</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>08</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>11</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Kosarac, Kubwabo, Katuri, Petraccone and Mischki.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Kosarac, Kubwabo, Katuri, Petraccone and Mischki</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>During the summer of 2019, cases of lung injury associated with vaping emerged in North America, including among individuals who reported exclusive use of nicotine vaping liquids. Once vitamin E acetate was identified as a potential causative agent a quantitative method based on a simple sample dilution, separation by gas chromatography and analysis by triple quadrupole mass spectrometry (GC MSMS) was developed. Method detection limit (MDL) and limit of quantification (LOQ) were determined at 0.159&#xa0;&#xb5;g/mL and 0.505&#xa0;&#xb5;g/mL, respectively. The analysis was performed on a subset of 203 commercially sourced nicotine containing vaping liquids of various flavour profile and nicotine range (nicotine free-59&#xa0;mg/mL) from an internal inventory. The target analyte, Vitamin E Acetate, was not detected in any samples analyzed, as expected, given the reported detection in literature and high association of the chemical with cannabis and not nicotine containing vaping products.</p>
</abstract>
<kwd-group>
<kwd>vaping</kwd>
<kwd>vitamin E acetate</kwd>
<kwd>medium chain triglycerides</kwd>
<kwd>aerosol</kwd>
<kwd>nicotine</kwd>
<kwd>gc ms</kwd>
<kwd>emission</kwd>
<kwd>cannabis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Emissions profiles of vitamin E acetate and Medium Chain Triglycerides (MCT) oil were also characterized <italic>via</italic> non-targeted analysis, using GC-MS/MS, to identify potential chemical analytes generated when liquids were heated. The emissions were generated under standardized conditions using a vaping machine and a vaporizer device designed for use with cannabis concentrates. Vitamin E acetate emissions mainly contained target analyte itself, while MCT oil emissions were more chemically complex, as expected due to the presence of various triglycerides in the un-vaped oil. Of note even following rigorous cleaning procedures of the device and contact parts with a number of chemical solvents and replacement of consumable parts between MCT oil and vitamin E acetate vaping sessions, cross-contamination was observed. This cross contamination and residue persistence, is indicative of a real-life scenario where users may share or use the same device with a number of different products or formulations and not be aware of potential exposures to diluents of concern.</p>
<sec id="s1">
<title>Introduction</title>
<p>E-cigarettes or vaping products are battery-powered, alternative nicotine delivery systems that vaporize a formulation of vaping liquid or e-liquid. The liquids most commonly contain carrier solvents, propylene glycol (PG) and/or vegetable glycerine (VG), nicotine and flavours. Once heated, the formulation generates additional chemical compounds in the emissions, resulting in a complex exposure pattern to users of these products. Nevertheless, in spite of potential health risks, vaping provides nicotine delivery with lower exposures to chemicals of concern for the individuals who smoke (<xref ref-type="bibr" rid="B7">Goniewicz et&#x20;al., 2018</xref>). One of the main appealing characteristics of vaping products is the fact that they come in thousands of flavours and in various nicotine concentrations. Although some vaping products are available in a more closed, pod format, many products and flavour choices are available in open format. Users of open systems can refill or customize vaping liquids to be used, the most frequently, with a modifiable, custom power setting, vaping device. The vaping or heating principle is also used for delivery of other substances such as those containing cannabidiol (CBD) and tetrahydrocannabinol (THC) cannabis vaping products.</p>
<p>Vitamin E acetate or alpha tocopherol acetate is the stabilized form of vitamin E often used as food additive or nutrient supplement (<xref ref-type="bibr" rid="B14">National Library of Medicine 2021c</xref>). Medium chain triglycerides and vitamin E acetate are, reportedly, added to the vaping products in order to dilute the illicit THC-containing liquids and lower their costs. Moreover, diluents are also used in order to improve products&#x2019; appearance and flavour (<xref ref-type="bibr" rid="B3">Blount et&#x20;al., 2020</xref>). Although ingestion of vitamin E acetate is thought to have nutritional and health benefits, the inhalation exposure studies in animals suggest a severe lung damage and impaired function (<xref ref-type="bibr" rid="B2">Bhat et&#x20;al., 2020</xref>). Moreover, the recent studies on various diluents (coconut oil, medium-chain triglycerides, Vitamin E Acetate, etc) in <italic>in-vitro</italic> models have observed an increased cytotoxicity in human airway epithelial cells (<xref ref-type="bibr" rid="B11">Jiang et&#x20;al., 2020</xref>) however, their effects in humans are still being investigated.</p>
<p>During the summer of 2019, cases of lung injury associated with vaping (vaping-associated lung illness (VALI (Canada)) or e-cigarette associated lung injury [EVALI (United&#x20;States)] emerged in North America. In the course of investigation, illegal cannabis vaping products containing vitamin E acetate were found to be strongly associated and thought to be the most likely cause of the outbreak in the majority of cases in the United&#x20;States (<xref ref-type="bibr" rid="B4">CDC 2020</xref>), as observed through laboratory analysis of patients&#x2019; biological and illicit THC product samples (<xref ref-type="bibr" rid="B3">Blount et&#x20;al., 2020</xref>). MCT oil, to date, has not been reported as a cause of related adverse occurrence.</p>
<p>In 2019, when vitamin E acetate from the illicit products was identified as a potential causative agent of EVALI in the United&#x20;States, new analytical method to quantify this target analyte in the Canadian vaping samples was developed. At the time, cannabis vaping products were illegal in Canada, so the analysis was carried out on the nicotine-containing products. Moreover, since the data on chemical transformations and constituents of emissions generated from heating of the pure vitamin E acetate were lacking, we characterized the same and identified chemicals relevant for the inhalation exposures. In addition to Vitamin E Acetate emission, MCT oil emission was characterized as well, and the main constituents are reported&#x20;here.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Chemicals and Reagents</title>
<p>99.7% pure propylene glycol and 99.2% pure glycerol were purchased from Sigma-Aldrich (Oakville, Canada). HPLC grade methanol, acetonitrile and hexane were purchased from Fisher Scientific (Ottawa, Canada). Vitamin E acetate (D, L-&#x3b1;-Tocopherol acetate) (&#x2265;99%) analytical standard was purchased from Sigma-Aldrich (Oakville, Canada).</p>
</sec>
<sec id="s2-2">
<title>Samples</title>
<p>Two hundred and three vaping liquids from over 70 manufacturers were collected between 2017 and 2019 from online and brick and mortar stores in Canada. These products were chosen at random from a larger pool of samples collected for a project on characterization of nicotine vaping liquids. The on-product labelled nicotine concentration varied between nicotine-free and 59&#xa0;mg/mL (<xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>) and 20% of products were labelled to contain nicotine&#x20;salts.</p>
<p>A majority of samples were packaged in glass or plastic 30&#xa0;mL, refillable bottles and each one was classified into one of 18 flavour categories as per manufacturer&#x2019;s declared flavour or based on product descriptions (<xref ref-type="sec" rid="s9">Supplementary Figure S2</xref>). Flavour classification wheel was adapted for vaping products on Canadian market and based on previously reported approach (<xref ref-type="bibr" rid="B12">Kr&#xfc;semann et&#x20;al., 2019</xref>).</p>
<p>Medium Chain Triglyceride (MCT) oil from coconut oil (60% caprylic acid (C8)/40% capric acid (C10)-St. Francis, Herb Farm) was obtained from a local health food store in Ottawa, Canada. Vaping device used to generate emissions was Pax 3 (PAX, Labs) dual-use vaporizer device with concentrate insert consisting of aluminum oven purchased in vaping store in Ottawa, Canada.</p>
</sec>
<sec id="s2-3">
<title>Chemical Analysis</title>
<p>Two analytical methods were developed one for targeted analysis and determination of concentration of vitamin E acetate in vaping liquids, and another one for characterization of emissions generated from MCT oil and vitamin E acetate.</p>
</sec>
<sec id="s2-4">
<title>Targeted Analysis of Vaping Liquids</title>
<p>The sample preparation was a simple dilution in methanol. Following a thorough sample mixing, 40&#xa0;mg of sample measured to the nearest 0.1&#xa0;mg was diluted in a 20&#xa0;mL volumetric flask and made up to volume with methanol. Upon dilution and vortex mixing, 1&#xa0;&#xb5;L of diluted sample was injected and analyzed using Thermo Ultra Trace GC (gas chromatograph) coupled to Quantum TSQ tandem mass spectrometer (MS/MS) (Thermo Elec. Missisausgua, Canada). The chromatographic separation was achieved on a Zebron ZB-1HT GC capillary column (15 &#xd7; 0.25&#xa0;mm x 0.1&#xa0;&#xb5;m) from Phenomenex (CA, United&#x20;States). The injector temperature was set at 280&#xb0;C and injection mode used was splitless. The GC oven temperature program was as follows: 120&#x2013;200&#xb0;C at 20&#xb0;C/min, followed by 10&#xb0;C/min to 290&#xb0;C and holding for 1&#xa0;min, and reaching 320&#xb0;C at 20&#xb0;C/min and finally holding for 3&#xa0;min. Helium was the carrier gas at a flow rate of 1&#xa0;mL/min in constant flow mode. The source and GC interface temperatures were set at 180 and 250&#xb0;C, respectively. The mass spectrometer was operated in electron ionization at 70&#xa0;eV in multiple-reaction monitoring (MRM) mode using argon as a collision gas. Xcalibur data system was used for data acquisition and processing. The following MRM transitions were optimized for vitamin E acetate quantifier ion: 430.3 &#x2192; 165.05 with collision energy of 20&#xa0;eV and qualifier ion: 472.1 &#x2192; 430.75 with collision energy of 10&#xa0;eV. The calibration was achieved using the standard addition method. Each individual calibration standard level was prepared using the aliquots of diluted sample and fortifying with target analyte, Vitamin E acetate. The calibration curve was linear in the concentration range 0.025-12.5&#xa0;&#xb5;g/mL.</p>
</sec>
<sec id="s2-5">
<title>Method Performance and Validation</title>
<p>Method performance was assessed according to the EPA Regulation 40 CFR part 136 (Appendix B) method (<xref ref-type="bibr" rid="B27">USEPA 2011</xref>). Eight replicates of vaping sample with no detectable levels of vitamin E acetate were fortified with vitamin E acetate at 0.50&#xa0;&#xb5;g/mL, diluted with methanol and analyzed. The standard deviation associated with eight replicate analyses of fortified vaping liquid, was multiplied by the Student&#x2019;s t value of 2.998 (appropriate for a 99% confidence level with 7 degrees of freedom). The method detection limit (MDL) for vitamin E acetate was calculated to be 0.159&#xa0;&#xb5;g/mL or 0.18&#xa0;&#xb5;g/g. The limit of quantitation (LOQ) was calculated according to the US EPA method, where the standard deviation associated with the eight replicate analyses of fortified vaping liquid was multiplied by a factor of 10. The LOQ was calculated to be 0.505&#xa0;&#xb5;g/mL.</p>
<p>Laboratory blanks consisting of methanol and vaping liquid containing <italic>p</italic>G/VG (50/50 v/v) prepared in laboratory were used to assess carry-over between injections and any possible contamination. Since the analytical methodology did not employ the use of internal standard nor extraction sample clean up, the measures of analyte recovery were irrelevant. However, using the standard addition calibration and quality control sample fortified at 0.50&#xa0;&#xb5;g/mL, processed as eight repeats on a single day and as a repeated QC sample in 4 analysed sample batches, accuracy and precision (%RSD) were determined as 6.9 and 18.1%, respectively.</p>
<sec id="s2-5-1">
<title>Characterization of Vitamin E Acetate and Medium-Chain Triglycerides Oil, and Vaping Emissions</title>
<sec id="s2-5-1-1">
<title>Emission Generation</title>
<p>Approximately 150&#xa0;mg of vitamin E acetate or MCT oil were placed in the aluminum, concentrate, oven insert of a Pax 3 device. The mouthpiece was connected to a CETI 8 vaping machine (Cerulean, United&#x20;States) and the Pax 3 was set to 215&#xb0;C, (maximum device temperature setting). Generation of vaped emissions was achieved using the ISO 20768 puffing regimen of 55&#xa0;ml square wave puff, over 3&#xa0;s, once every 30&#xa0;s (<xref ref-type="bibr" rid="B10">(ISO) 2018</xref>). Ten puffs of each vitamin E acetate or MCT oil were collected on solvent pre-cleaned collection pads. Device weight was recorded prior and after vaping. Collection pads were extracted twice with 5&#xa0;mL of methanol. Extracts were combined and 1&#xa0;&#xb5;L of extract was injected and analyzed using GC&#x20;MS.</p>
</sec>
<sec id="s2-5-1-2">
<title>Analysis of Diluents of Concern and Their Emissions</title>
<p>The Quantum TSQ MS/MS instrument coupled to a Trace GC Ultra gas chromatograph (Thermo Electron Corp.) was operated in a full-scan acquisition mode. The oven ramp programing was identical to the one used for targeted analysis of Vitamin E Acetate. The MS was operated in Electron Ionization, full-scan mode with scan range 35&#x2013;600&#xa0;m<italic>/z</italic> and emission current set at 100&#xa0;&#xb5;A. GC separation was performed using Zebron ZB-1HT GC capillary column (15 &#xd7; 0.25&#xa0;mm x 0.1&#xa0;&#xb5;m) from Phenomenex (CA, United&#x20;States). The injector temperature was set at 280&#xb0;C with splitless injection mode. GC carrier gas was helium operated in constant flow mode at 1&#xa0;mL/min rate. The spectrum of detected compounds was matched against spectra from the National Institute of Standards and Technology (NIST 17) library reference&#x20;peaks.</p>
</sec>
</sec>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>Results and Discussion</title>
<sec id="s3-1">
<title>Vitamin E Acetate in Nicotine-Containing Vaping Liquids</title>
<p>During the development of the targeted method matrix effects were observed due to the presence of carrier solvents PG and VG, <xref ref-type="fig" rid="F1">Figure&#x20;1</xref>.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Vitamin E acetate extracted quantifier (Q1) and qualifier (Q2) ion transitions. <bold>(A)</bold> Sample 202. <bold>(B)</bold> Fortified sample 202&#xa0;at 2.5&#xa0;&#xb5;g/mL of vitamin E acetate. <bold>(C)</bold> Pure vitamin E acetate diluted in methanol at 2.5&#xa0;&#xb5;g/mL (no matrix present).</p>
</caption>
<graphic xlink:href="fchem-09-756745-g001.tif"/>
</fig>
<p>In order to account for matrix effects the six level calibration was performed using the standard addition method, where diluted samples were fortified with known concentrations of Vitamin E Acetate. The analytical blank samples revealed no background contamination or in-between sample carry-over.</p>
<p>During the early reporting of EVALI, it was not clear which vaping product&#x2019;s (nicotine or cannabis) constituents were related to the cases of the outbreak. Since the cannabis vaping products only became legal for sale in Canada in late 2019 (<xref ref-type="bibr" rid="B8">Government of Canada 2019</xref>) and would only have entered the marketplace towards mid-to end of December 2019 or early 2020, we screened the legal nicotine-containing products. The analytical method was applied to 203&#x20;nicotine-containing vaping liquids in order to quantify Vitamin E Acetate. The target analyte was not detected above limit of detection (0.159&#xa0;&#xb5;g/mL) in any products analyzed. To date and to our knowledge no nicotine-vaping liquids have been reported to contain Vitamin E Acetate. In fact nicotine-containing vaping products&#x2019; ingredient reports from cartridges and refill containers (41,809), were assessed for the presence of vitamin E acetate and THC by United&#x20;Kingdom Centre for Tobacco and Alcohol Studies (<xref ref-type="bibr" rid="B18">Nyakutsikwa et&#x20;al., 2020</xref>). Although no actual chemical analysis was conducted, the assessment of reported ingredients had found no Vitamin E Acetate and THC present. The chemical matrix of cannabis vaping liquids differs from that of nicotine containing vaping products due to distinct chemical properties of active ingredients added to the products. Cannabinoids are hydrophobic and typically diluted with oils or other, more hydrophobic diluents, while nicotine is diluted in more polar, alcohol-based diluents. Nicotine formulations in fact, often contain water (Crenshaw et&#x20;al., 2016). While vitamin E acetate is a suspected cause of majority of EVALI cases in United&#x20;States, more than half of cases reported in Canada appear to be associated with nicotine-containing vaping liquids (<xref ref-type="bibr" rid="B9">Government Of Canada 2020</xref>). Up to the August of 2020, 20 cases of VALI were reported in Canada, with 11 cases associated with nicotine containing vaping liquids only, however this is based on self-reporting and is not laboratory verified through testing of patients&#x2019; biological samples for presence of active substances (THC, nicotine, etc) or substances of concern (Vitamin E Acetate). The causes of these cases are an area of continued monitoring.</p>
<p>Reported analytical methods for the targeted analysis or quantification of vitamin E Acetate in vaping liquids and generated aerosols are limited, particularly for nicotine-containing products. In the VALI cases, mainly in the illicit cannabis vaping products, Vitamin E Acetate was quantified in relatively high concentrations since it was used as a diluent (<xref ref-type="bibr" rid="B5">Duffy et&#x20;al., 2020</xref>). In analyzing such samples, analytical method&#x2019;s detection sensitivity may not be of a concern; however, to date, toxicologically relevant concentrations of Vitamin E Acetate for inhalation exposures remain unknown; therefore, analytical methods that can detect the low levels of Vitamin E Acetate may be of interest as well. In a study by German federal institute for risk assessment (BfR), LC-MS/MS based method was developed to detect Vitamin E and Vitamin E Acetate in e-liquids with limit of detection for latter of 0.3&#xa0;ng per Gram of e-liquid (<xref ref-type="bibr" rid="B23">The German Federal Institute for Risk Assessment (BfR) 2020</xref>). Although the method is more sensitive than method presented here (MDL &#x3d; 18&#xa0;ng per Gram of liquid), BfR method requires sample mass of 500&#xa0;mg for analysis compared to 40&#xa0;mg required in our methodology. Developing the methods that use small sample volume or weight is advantageous as often times, in the real cases of EVALI, forensic labs will only have a residue of vaping liquid, i.e. what remains in the device to be used for testing and not necessarily significant amounts of the product left. In other studies from the United&#x20;States, LC-MS/MS methods were developed for analysis of Vitamin E Acetate in vaping products that contain tetrahydrocannabinol (THC) acquired from informal sources from Minnesota (<xref ref-type="bibr" rid="B22">Taylor et&#x20;al., 2019</xref>) and in trapped aerosol emissions from e-cigarette, or vaping products associated with EVALI cases in United&#x20;States (<xref ref-type="bibr" rid="B21">Puetz et&#x20;al., 2021</xref>). Vitamin E acetate was also detected in THC cartridges and in bronchoalveolar lavage fluid from EVALI patients in Wisconsin United&#x20;States (<xref ref-type="bibr" rid="B20">Pray et&#x20;al., 2020</xref>). THC/VEA mixtures were vaped at elevated power levels in vaping device to study the VEA decomposition by GC/MS in Forensic Chemistry Center, United&#x20;States (<xref ref-type="bibr" rid="B13">Lynch et&#x20;al., 2021</xref>). Most of the reported studies lack detailed information on the method detection limits, validation data, sample preparation, and sample&#x20;size.</p>
</sec>
<sec id="s3-2">
<title>Medium Chain Triglyceride Oil</title>
<p>The saturated fatty acids of mixed triacylglycerols with 6&#x2013;10 carbons chains are collectively referred to as medium chain triglyceride oil. MCT oil is included in a generally recognized as safe (GRAS) substances for human consumption (<xref ref-type="bibr" rid="B26">Traul et&#x20;al., 2000</xref>). They are sourced from plant oil sources such as coconut and palm oils. This study used MCT oil from coconut which according to product label, was comprised of 60% caprylic acid (C8) and 40% capric acid (C10) triglycerides. Prior to heating and emission generation, chemical characterization of this oil was conducted to better understand the starting composition. Four major mixed triacylglyceride constituents were detected&#x20;(Trioctanoin (8:0/8:0/8:0), glyceryl 2-caprate dicaprylate (8:0/8:0/10:0); glyceryl 2-caprylate dicaprate (10:0/10:0/8:0) and tricaprin (10:0/10:0/10:0), <xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>). In addition to major constituents, earlier eluting chemical compounds included two anhydrides caprylic and decanoic, as well as octanoic acid, 2-propenyl ester (imitation fatty, fruity, pineapple flavour agent) (<xref ref-type="bibr" rid="B24">The Good Scents Company 2021b</xref>) and four diacylglycerides, <xref ref-type="fig" rid="F2">Figure&#x20;2B</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>
<bold>(A)</bold> MCT oil scan, concentration 2000&#xa0;&#xb5;g/mL; <bold>(B)</bold> Earlier eluting compounds area enlarged.</p>
</caption>
<graphic xlink:href="fchem-09-756745-g002.tif"/>
</fig>
<p>
<xref ref-type="table" rid="T1">Table&#x20;1</xref> contains detailed information on detected chemical compounds. Open source databases, Pubchem (<xref ref-type="bibr" rid="B16">National Library of Medicine 2021b</xref>), NIST Chemistry WebBook (<xref ref-type="bibr" rid="B17">(NIST) 2021</xref>) and The Good Scents Company Information System (<xref ref-type="bibr" rid="B25">The Good Scents Company 2021a</xref>) were used to extract more information about and typical use for detected chemicals.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Chemical compounds detected in MCT oil (Refer to <xref ref-type="fig" rid="F2">Figures 2</xref>, <xref ref-type="fig" rid="F3">3</xref>).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Peak</th>
<th align="center">IUPAC Name</th>
<th align="center">Common Name</th>
<th align="center">CASRN</th>
<th align="center">More information</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">1</td>
<td align="left">Octanoyl octanoate</td>
<td align="left">n-Caprylic Anhydride</td>
<td align="center">623-66-5</td>
<td align="left">Listed in cosmetic products patents</td>
</tr>
<tr>
<td align="left">2</td>
<td align="left">Prop-2-enyl octanoate</td>
<td align="left">Octanoic acid, 2-propenyl ester</td>
<td align="center">4230-97-1</td>
<td align="left">Flavour and fragrance agent; Fatty, fruity, pineapple tropical-like flavour</td>
</tr>
<tr>
<td align="left">3</td>
<td align="left">[(2S)-3-hydroxy-2-octanoyloxypropyl] octanoate</td>
<td align="left">Octanoic acid, 1-(hydroxymethyl)-1,2-ethanediyl ester, (S)-</td>
<td align="center">60514-48-9</td>
<td align="left">Common food additives used to blend together certain ingredients, such as oil and&#xa0;water, which would not otherwise blend well. Diacylglycerols are often found in bakery products, beverages,&#xa0;ice&#xa0;cream, chewing gum, shortening, whipped toppings, margarine, and confections</td>
</tr>
<tr>
<td align="left">4</td>
<td align="left">(2-hydroxy-3-octanoyloxypropyl) octanoate</td>
<td align="left">1,3-Dioctanoin</td>
<td align="center">1429-66-9</td>
<td align="left">Metabolite of rapeseed</td>
</tr>
<tr>
<td align="left">5</td>
<td align="left">Decanoyl decanoate</td>
<td align="left">Decanoic anhydride</td>
<td align="center">2082-76-0</td>
<td align="left">&#x2014;</td>
</tr>
<tr>
<td align="left">6</td>
<td align="left">(1-hydroxy-3-octanoyloxypropan-2-yl) decanoate</td>
<td align="left">Decanoic acid, 1-(hydroxymethyl)-2-[(1-oxooctyl)oxy]ethyl ester</td>
<td align="center">177717-46-3</td>
<td align="left">Patents list personal care product and emulsion formulations use</td>
</tr>
<tr>
<td align="left">7</td>
<td align="left">(2-hydroxy-3-octanoyloxypropyl) decanoate</td>
<td align="left">Glyceryl 1-caprate-3-caprylate</td>
<td align="center">93980-84-8</td>
<td align="left">Patents list use in surfactants</td>
</tr>
<tr>
<td align="left">8</td>
<td align="left">2,3-di(octanoyloxy)propyl octanoate</td>
<td align="left">Trioctanoin</td>
<td align="center">538-23-8</td>
<td align="left">Has a role as a plant metabolite. Used as diluent, as carrier for flavours and essential oils</td>
</tr>
<tr>
<td align="left">9</td>
<td align="left">1,3-di(octanoyloxy)propan-2-yl decanoate</td>
<td align="left">Glyceryl 2-caprate dicaprylate</td>
<td align="center">33368-87-5</td>
<td align="left">Triglyceride 8:0/8:0/10:0, patents list use in printing inks and varnishes</td>
</tr>
<tr>
<td align="left">10</td>
<td align="left">(3-decanoyloxy-2-octanoyloxypropyl) decanoate</td>
<td align="left">Glyceryl 2-caprylate dicaprate</td>
<td align="center">33368-86-4</td>
<td align="left">Triglyceride 8:0/10:0/10:0, patents list use in printing inks and varnishes</td>
</tr>
<tr>
<td align="left">11</td>
<td align="left">2,3-di(decanoyloxy)propyl decanoate</td>
<td align="left">Tricaprin</td>
<td align="center">621-71-6</td>
<td align="left">Precursor of&#xa0;decanoic acid&#xa0;(DA), a 10-carbon fatty acid (Triglyceride 10:0/10:0/10:0) and major component of medium chain triglyceride oils. Used in dietary and cosmetic products as emollient and solvent</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Generated emissions of heated MCT oil in Pax 3 device were captured, extracted in methanol and analyzed (<xref ref-type="fig" rid="F3">Figure&#x20;3</xref>). The analysis of ten puffs revealed presence of nine of eleven chemical compounds detected in the unvaped MCT&#x20;oil.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>MCT oil emission scan, concentration 920&#xa0;&#xb5;g/ml.</p>
</caption>
<graphic xlink:href="fchem-09-756745-g003.tif"/>
</fig>
<p>Two chemicals that were not detected in the emissions were tricaprin (10:0/10:0/10:0 triglyceride), and decanoic anhydride. Comparing the chemical profile of unvaped MCT oil and compounds generated in the emissions it is evident that the absolute ratio of triglycerides changes, presumably due to the transformation during heating process or perhaps due to the varying degrees of transfer from oil into emissions given the differences in boiling points among the triglycerides. The exact concentrations of each generated chemical were not quantified as calibration and genuine analytical standards were not used. Instead, the overall concentration of MCT oil mixture was estimated using the mass loss before and after vaping and by weighing the collection&#x20;pad.</p>
<p>Thinning agents such as vegetable glycerine, propylene glycol or poly ethylene glycol are used as diluents of cannabis vaping oils (<xref ref-type="bibr" rid="B6">Erickson 2019</xref>; <xref ref-type="bibr" rid="B11">Jiang et&#x20;al., 2020</xref>). MCT oils have also been reported to be used in some cannabis products, however, to date and in comparison with Vitamin E Acetate, MCT oil has been less frequently detected in the samples associated with cases of EVALI in the United&#x20;States (<xref ref-type="bibr" rid="B3">Blount et&#x20;al., 2020</xref>).</p>
</sec>
<sec id="s3-3">
<title>Vitamin E Acetate</title>
<p>The same procedure was followed with vitamin E acetate as with MCT oil. Vitamin E acetate was diluted in methanol and analyzed using the non-targeted or scanning protocol. This substance was of a high grade and purity as confirmed by the analysis where two isomers, dexter (D) and laevus (L) were detected as major compounds. Only one other compound was detected in the tested material and that is methyl stearate, flavouring and cosmetics agent as well as plant metabolite (<xref ref-type="bibr" rid="B15">National Library of Medicine 2021a</xref>), <xref ref-type="fig" rid="F4">Figure&#x20;4</xref> and <xref ref-type="table" rid="T2">Table&#x20;2</xref>.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>D, L Vitamin E acetate scan, concentration 2000&#xa0;&#xb5;g/ml.</p>
</caption>
<graphic xlink:href="fchem-09-756745-g004.tif"/>
</fig>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Chemical compounds detected in Vitamin E Acetate (<xref ref-type="fig" rid="F4">Figure&#x20;4</xref>).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Peak</th>
<th align="center">IUPAC Name</th>
<th align="center">Common Name</th>
<th align="center">CASRN</th>
<th align="center">More information</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">1</td>
<td align="left">Methyl octadecanoate</td>
<td align="left">Methyl stearate</td>
<td align="center">112-61-8</td>
<td align="left">Found in cloves. Used as cosmetics and fragrance agent. Plant metabolite</td>
</tr>
<tr>
<td align="left">2</td>
<td align="left">[2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydrochromen-6-yl] acetate</td>
<td align="left">D,L Vitamin E acetate or (&#xb1;)-&#x3b1;-Tocopherol acetate</td>
<td align="center">7695-91-2</td>
<td align="left">Synthetic D,L form. Antioxidant, nutritional supplement and preservative</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Aluminium oven from Pax 3 device was filled with Vitamin E Acetate, weight recorded and used to generate ten puffs on CETI 8 vaping machine. The emissions were collected on the chemically pre-cleaned collection pad which in turn was extracted with methanol and analyzed using the scanning protocol. It is important to note that the same Pax3 device was used to vape MCT oil first, and then D, L Vitamin E Acetate. Five chemical compounds were detected in D, L vitamin E acetate emission, <xref ref-type="fig" rid="F5">Figure&#x20;5</xref> and <xref ref-type="table" rid="T3">Table&#x20;3</xref>.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>D, L vitamin E acetate emission scan, concentration 870&#xa0;&#xb5;g/mL, including two MCT oil cross-contaminants.</p>
</caption>
<graphic xlink:href="fchem-09-756745-g005.tif"/>
</fig>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Chemical compounds detected in vitamin E acetate emission (<xref ref-type="fig" rid="F5">Figure&#x20;5</xref>).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Peak</th>
<th align="center">IUPAC Name</th>
<th align="center">Common Name</th>
<th align="center">CASRN</th>
<th align="center">More information</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">1</td>
<td align="left">Methyl 16-methylheptadecanoate</td>
<td align="left">Methyl isostearate</td>
<td align="center">5129-61-3</td>
<td align="left">Natural substance and extractive, used in cosmetic products</td>
</tr>
<tr>
<td align="left">2</td>
<td align="left">2,3-di(octanoyloxy)propyl octanoate</td>
<td align="left">Trioctanoin</td>
<td align="center">538-23-8</td>
<td align="left">Has a role as a plant metabolite. Used as diluent, as carrier for flavours and essential oils</td>
</tr>
<tr>
<td align="left">3</td>
<td align="left">1,3-di(octanoyloxy)propan-2-yl decanoate</td>
<td align="left">Glyceryl 2-caprate dicaprylate</td>
<td align="center">33368-87-5</td>
<td align="left">Triglyceride 8:0/8:0/10:0, patents list use in printing inks and varnishes</td>
</tr>
<tr>
<td align="left">4</td>
<td align="left">[2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydrochromen-6-yl] acetate</td>
<td align="left">D,L Vitamin E Acetate or (&#xb1;)-&#x3b1;-Tocopherol acetate</td>
<td align="center">7695-91-2</td>
<td align="left">Synthetic D,L form. Antioxidant, nutritional supplement and preservative</td>
</tr>
<tr>
<td align="left">5</td>
<td align="left">(3-decanoyloxy-2-octanoyloxypropyl) decanoate</td>
<td align="left">Glyceryl 2-caprylate dicaprate</td>
<td align="center">33368-86-4</td>
<td align="left">Triglyceride 8:0/10:0/10:0, patents list use in printing inks and varnishes</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The major constituent of the emission was one racemic structure (D or L) of vitamin E acetate and a minor constituent was Methyl isostearate. Additional three chemicals detected in the emissions were most likely due to the cross-contamination with MCT oil emissions as they have been previously detected in the oil itself and its&#x2019; emission. Although in between the samples, the mouthpiece was replaced, an aluminium concentrate insert heating oven was thoroughly cleaned as per manufacturer&#x2019;s instructions, and through the use of various laboratory chemical solvents (hexane, acetonitrile, methanol), the analysis of vitamin E acetate generated emissions, unfortunately, revealed the presence of MCT oil compounds as well. The cross-contamination did not result from the GC MS instrument carry over or instrument contamination as the analytical blanks injected between samples showed no detected MCT oil compounds. Although it was not confirmed through laboratory analysis, it is likely that the contamination originated from the heating element on the outside of the oven or from the other parts of the device that could have gotten into contact through emission path. Some interior device parts were not rinsed thoroughly with solvents as they could be damaged, and therefore, were a likely source of MCT oil triglycerides.</p>
<p>The cross contamination, although unfortunate, can be indicative of a real-life occurrence where users may use the same device to vaporize or vape a number of different products or formulations, and unintentionally get exposed to chemical transformation products that may not necessarily match vaping liquid they are consuming in spite of a thorough device cleaning. Of a particular concern may also be the cases where a device is shared or borrowed among users - a social behaviour previously documented among youth who vape (<xref ref-type="bibr" rid="B19">Pepper et&#x20;al., 2019</xref>). In such cases, cross-contamination or persistence of diluent of concern in the vaping device may lead to lack of awareness and unintentional exposure of additional&#x20;users.</p>
</sec>
<sec id="s3-4">
<title>Limitations</title>
<p>The vitamin E acetate targeted method presented here was not applied to any cannabis-containing vaping products, therefore, no conclusions can be made on presence of this diluent in cannabis products in Canada. Vitamin E acetate (D, L) emissions in our study were generated using 96% pure compound. The chemical grade of vitamin E acetate used as diluent for illicit cannabis vaping products may contain more impurities and be of a lower grade. In the absence of real cannabis sample or type of diluent used, it is difficult to conclude whether the impurities from the technical grade product would be present in the emissions.</p>
<p>While this study provides an improved understanding of chemical profiles of emissions of vaping diluents, caution should be taken when interpreting these results in real-world conditions. In order to study formation of chemical transformations, the liquid diluents were studied individually and not in vaping liquid mixtures which most frequently will include other diluents (PG or VG), flavours, processing agents and active ingredients (nicotine, THC,&#x20;etc).</p>
<p>Recent studies on pyrolysis of vitamin E acetate have hypothesized and detected a presence of a simple ketene-ethenone, an acute lung irritant and highly reactive compound (<xref ref-type="bibr" rid="B28">Wu and O&#x2019;Shea 2020</xref>). We did not detect this chemical compound in the emissions as it is likely that our pad capturing method was not sufficient to collect this highly volatile compound. Another reason could also be that the device used in our study was heating only to 215&#xb0;C that may not have been sufficient temperature to generate this compound (<xref ref-type="bibr" rid="B1">Attfield et&#x20;al., 2020</xref>). Further studies are required to capture and characterize the highly volatile chemical compounds generated in the vaped emissions.</p>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>Conclusion</title>
<p>In our study, Vitamin E Acetate was not detected above detection limit (0.159&#xa0;&#xb5;g/mL) in any nicotine containing vaping liquids analyzed. Two diluents of concern-Vitamin E Acetate and medium chain triglycerides, were analyzed as pure substances in order to better characterize their emissions. Both diluents when heated in vaping device in fact, generate high concentrations of diluents as well as other chemical compounds typically present in unvaped precursor material. Of a note is that there was an observed cross-contamination of vaping device with diluents used which may have implications for device sharing. Although Vitamin E Acetate has been identified as a potential causative agent in the occurrence of EVALI, MCT oil, to date has not been directly implicated in EVALI. Moreover, to date the cause of cases related to the exclusive use of nicotine-containing vaping products has not been determined. Future studies should characterize vaped emissions from the products of interest in order to better elucidate chemicals of concern.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s10">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>IK conceived, designed and performed the chemical analysis, supervised data processing and wrote the manuscript. CK supervised the targeted analysis of vitamin E acetate and reviewed the manuscript. GK performed the chemical analysis and revised the manuscript. DP generated the emissions, performed the analysis and revised the manuscript. TM conceived the project, supervised the project coordination, discussed results and revised the manuscript.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>This project was funded by Government of Canada, Health Canada.</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>The authors would like to acknowledge Adam Doane for discussions on study design and results.</p>
</ack>
<sec id="s10">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fchem.2021.756745/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fchem.2021.756745/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Image2.TIF" id="SM1" mimetype="application/TIF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image1.TIF" id="SM2" mimetype="application/TIF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Attfield</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Cummings</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Jacob</surname>
<given-names>P.</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>O&#x2019;Shea</surname>
<given-names>D. F.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Potential of Ethenone (Ketene) to Contribute to Electronic Cigarette, or Vaping, Product Use-Associated Lung Injury</article-title>. <source>Am. J.&#x20;Respir. Crit. Care Med.</source> <volume>202</volume> (<issue>8</issue>), <fpage>1187</fpage>&#x2013;<lpage>1189</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.202003-0654le</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhat</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Kalathil</surname>
<given-names>S. G.</given-names>
</name>
<name>
<surname>Bogner</surname>
<given-names>P. N.</given-names>
</name>
<name>
<surname>Blount</surname>
<given-names>B. C.</given-names>
</name>
<name>
<surname>Goniewicz</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Thanavala</surname>
<given-names>Y. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>An Animal Model of Inhaled Vitamin E Acetate and EVALI-like Lung Injury</article-title>. <source>N. Engl. J.&#x20;Med.</source> <volume>382</volume> (<issue>12</issue>), <fpage>1175</fpage>&#x2013;<lpage>1177</lpage>. <pub-id pub-id-type="doi">10.1056/nejmc2000231</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blount</surname>
<given-names>B. C.</given-names>
</name>
<name>
<surname>Karwowski</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Shields</surname>
<given-names>P. G.</given-names>
</name>
<name>
<surname>Morel-Espinosa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Valentin-Blasini</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gardner</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI</article-title>. <source>N. Engl. J.&#x20;Med.</source> <volume>382</volume> (<issue>8</issue>), <fpage>697</fpage>&#x2013;<lpage>705</lpage>. <pub-id pub-id-type="doi">10.1056/nejmoa1916433</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="web">
<collab>CDC, Centers for Disease Control and Prevention</collab> (<year>2020</year>). <article-title>Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping, Products</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html">https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html</ext-link>
</comment>. </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duffy</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Durocher</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dittmar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Delaney-Baldwin</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Analysis of Cannabinoid-Containing Fluids in Illicit Vaping Cartridges Recovered from Pulmonary Injury Patients: Identification of Vitamin E Acetate as a Major Diluent</article-title>. <source>Toxics</source> <volume>8</volume> (<issue>1</issue>), <fpage>8</fpage>. <pub-id pub-id-type="doi">10.3390/toxics8010008</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erickson</surname>
<given-names>Britt. E.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Cannabis Industry Gets Crafty with Terpenes</article-title>. <source>C&#x26;EN News</source> <volume>97</volume> (<issue>29</issue>), <fpage>18</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1021/cen-09729-feature1</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goniewicz</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>K. C.</given-names>
</name>
<name>
<surname>Blount</surname>
<given-names>B. C.</given-names>
</name>
<name>
<surname>Caldwell</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes</article-title>. <source>JAMA Netw. Open</source> <volume>1</volume> (<issue>8</issue>), <fpage>e185937</fpage>. <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2018.5937</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="web">
<collab>Government Of Canada</collab> (<year>2019</year>). <article-title>Final Regulations: Edible Cannabis, Cannabis Extracts, Cannabis Topicals</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/resources/regulations-edible-cannabis-extracts-topicals.html">https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/resources/regulations-edible-cannabis-extracts-topicals.html</ext-link>
</comment>. </citation>
</ref>
<ref id="B9">
<citation citation-type="web">
<collab>Government Of Canada</collab> (<year>2020</year>). <article-title>Vaping-associated Lung Illness</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.canada.ca/en/public-health/services/diseases/vaping-pulmonary-illness.html">https://www.canada.ca/en/public-health/services/diseases/vaping-pulmonary-illness.html</ext-link>
</comment>. </citation>
</ref>
<ref id="B10">
<citation citation-type="book">
<collab>(ISO), The International Organization for Standardization</collab> (<year>2018</year>). <source>ISO 20768:2018 Vapour Products - Routine Analytical Vaping Machine - Definitions and Standard Conditions</source>. </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>C. M. S.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Canchola</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Oswald</surname>
<given-names>I. W. H.</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Chemical and Toxicological Characterization of Vaping Emission Products from Commonly Used Vape Juice Diluents</article-title>. <source>Chem. Res. Toxicol.</source> <volume>33</volume> (<issue>8</issue>), <fpage>2157</fpage>&#x2013;<lpage>2163</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrestox.0c00174</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kr&#xfc;semann</surname>
<given-names>E. J. Z.</given-names>
</name>
<name>
<surname>Boesveldt</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>De Graaf</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Talhout</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>An E-Liquid Flavor Wheel: a Shared Vocabulary Based on Systematically Reviewing E-Liquid Flavor Classifications in Literature</article-title>. <source>Nicotine Tob. Res.</source> <volume>21</volume> (<issue>10</issue>), <fpage>1310</fpage>&#x2013;<lpage>1319</lpage>. </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lynch</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lorenz</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Brueggemeyer</surname>
<given-names>J.&#x20;L.</given-names>
</name>
<name>
<surname>Lanzarotta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Falconer</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Simultaneous Temperature Measurements and Aerosol Collection during Vaping for the Analysis of &#x394;9-Tetrahydrocannabinol and Vitamin E Acetate Mixtures in Ceramic Coil Style Cartridges</article-title>. <source>Front. Chem.</source> <volume>9</volume>, <fpage>734793</fpage>. <pub-id pub-id-type="doi">10.3389/fchem.2021.734793</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="web">
<collab>National Library of Medicine</collab> (<year>2021c</year>). <article-title>Alpha-Tocopherol Acetate</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/compound/alpha-Tocopherol-acetate#section=Food-Additives-and-Ingredients">https://pubchem.ncbi.nlm.nih.gov/compound/alpha-Tocopherol-acetate&#x23;section&#x3d;Food-Additives-and-Ingredients</ext-link>
</comment>. </citation>
</ref>
<ref id="B15">
<citation citation-type="web">
<collab>National Library of Medicine</collab> (<year>2021a</year>). <article-title>Methyl Stearate</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/compound/Methyl-stearate#section=Use-Classification">https://pubchem.ncbi.nlm.nih.gov/compound/Methyl-stearate&#x23;section&#x3d;Use-Classification</ext-link>
</comment>. </citation>
</ref>
<ref id="B16">
<citation citation-type="web">
<collab>National Library of Medicine</collab> (<year>2021b</year>). <article-title>PubChem</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/">https://pubchem.ncbi.nlm.nih.gov/</ext-link>
</comment>. </citation>
</ref>
<ref id="B17">
<citation citation-type="book">
<collab>(NIST), National Institute of Science and Technology</collab> (<year>2021</year>). <source>NIST Chemistry WebBook Standard Reference Database 69</source>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://webbook.nist.gov/chemistry/">https://webbook.nist.gov/chemistry/</ext-link>
</comment>. </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nyakutsikwa</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Britton</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bogdanovica</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Langley</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Vitamin E Acetate Is Not Present in Licit E&#x2010;cigarette Products Available on the UK Market</article-title>. <source>Addiction</source> <volume>115</volume> (<issue>4</issue>), <fpage>782</fpage>&#x2013;<lpage>783</lpage>. <pub-id pub-id-type="doi">10.1111/add.14920</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pepper</surname>
<given-names>J.&#x20;K.</given-names>
</name>
<name>
<surname>Coats</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Nonnemaker</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Loomis</surname>
<given-names>B. R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>How Do Adolescents Get Their E-Cigarettes and Other Electronic Vaping Devices?</article-title> <source>Am. J.&#x20;Health Promot.</source> <volume>33</volume> (<issue>3</issue>), <fpage>420</fpage>&#x2013;<lpage>429</lpage>. <pub-id pub-id-type="doi">10.1177/0890117118790366</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pray</surname>
<given-names>I. W.</given-names>
</name>
<name>
<surname>Atti</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Tomasallo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Meiman</surname>
<given-names>J.&#x20;G.</given-names>
</name>
</person-group> (<year>20202019</year>). <article-title>E-cigarette, or Vaping, Product Use-Associated Lung Injury Among Clusters of Patients Reporting Shared Product Use - Wisconsin, 2019</article-title>. <source>MMWR Morb. Mortal. Wkly. Rep.</source> <volume>69</volume> (<issue>9</issue>), <fpage>236</fpage>&#x2013;<lpage>240</lpage>. <pub-id pub-id-type="doi">10.15585/mmwr.mm6909a4</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puetz</surname>
<given-names>Andrew.</given-names>
</name>
<name>
<surname>Espinosa</surname>
<given-names>Maria. Morel.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>Clifford.</given-names>
</name>
<name>
<surname>Benjamin</surname>
<given-names>C. Blount.</given-names>
</name>
<name>
<surname>Valent&#xed;n-Blasini</surname>
<given-names>Liza.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Development, Validation, and Application of a Novel Method for the Analysis of Vitamin E Acetate and Other Tocopherols in Aerosol Emissions of E-Cigarettes, or Vaping Products Associated with Lung Injury</article-title>. <source>Front. Chem.</source> <volume>636</volume>. <pub-id pub-id-type="doi">10.3389/fchem.2021.730954</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wiens</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Saravia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lunda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Characteristics of E-Cigarette, or Vaping, Products Used by Patients with Associated Lung Injury and Products Seized by Law Enforcement - Minnesota, 2018 and 2019</article-title>. <source>MMWR Morb. Mortal. Wkly. Rep.</source> <volume>68</volume> (<issue>47</issue>), <fpage>1096</fpage>&#x2013;<lpage>1100</lpage>. <pub-id pub-id-type="doi">10.15585/mmwr.mm6847e1</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="web">
<collab>The German Federal Institute for Risk Assessment (BfR)</collab> (<year>2020</year>). <article-title>Determination of Vitamin E and Vitamin E Acetate in E-Liquids Using LC-MS/MS</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.bfr.bund.de/cm/349/Determination-of-Vitamin-E-and-Vitamin-E-Acetate%20.pdf">https://www.bfr.bund.de/cm/349/Determination-of-Vitamin-E-and-Vitamin-E-Acetate%20.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B24">
<citation citation-type="web">
<collab>The Good Scents Company</collab> (<year>2021b</year>). <article-title>Allyl Octanoate</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.thegoodscentscompany.com/data/rw1002871.html">http://www.thegoodscentscompany.com/data/rw1002871.html</ext-link>
</comment>. </citation>
</ref>
<ref id="B25">
<citation citation-type="web">
<collab>The Good Scents Company</collab> (<year>2021a</year>). <article-title>TGSC Information System</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.thegoodscentscompany.com/index.html">http://www.thegoodscentscompany.com/index.html</ext-link>
</comment>. </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Traul</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Driedger</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ingle</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Nakhasi</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Review of the Toxicologic Properties of Medium-Chain Triglycerides</article-title>. <source>Food Chem. Toxicol.</source> <volume>38</volume>, <fpage>79</fpage>&#x2013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/s0278-6915(99)00106-4</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="web">
<collab>USEPA, United&#x20;States Environmental Protection Agency</collab> (<year>2011</year>). <article-title>40 CFR Appendix B to Part 136&#x20;- Definition and Procedure for the Determination of the Method Detection Limit-Revision 1.11</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.govinfo.gov/app/details/CFR-2011-title40-vol23/CFR-2011-title40-vol23-part136-appB">https://www.govinfo.gov/app/details/CFR-2011-title40-vol23/CFR-2011-title40-vol23-part136-appB</ext-link>
</comment>. </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>O&#x2019;Shea</surname>
<given-names>D. F.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Potential for Release of Pulmonary Toxic Ketene from Vaping Pyrolysis of Vitamin E Acetate</article-title>. <source>Proc. Natl. Acad. Sci. USA</source> <volume>117</volume> (<issue>12</issue>), <fpage>6349</fpage>&#x2013;<lpage>6355</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1920925117</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>